article thumbnail

Who will regulate mHealth? Patient Engagement at Crossroads; New Alliance Takes On Interoperability

Chilmark Research

mHealth, known for rapid innovation and iteration, has a tendency to buck at the snail’s pace of FDA regulation. This could herald a new age of credibility for mHealth. They will need to tread carefully to maintain their objectivity in both certifying apps while at the same time providing a marketplace for mHealth apps.

mHealth 60
article thumbnail

The The Five Biggest Areas of Opportunity for Digital Health

The Digital Health Corner

Increasing healthcare consolidation of hospitals has exacerbated the problem of lack of interoperability. There remain many opportunities for technologies to assist in achieving true interoperability. From a provider standpoint. We need EHRs which are clinically oriented with good user interfaces. Clinical trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Three Big Questions for Stage 3 & Patient Engagement

Chilmark Research

For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. How Will the Market Respond?

article thumbnail

What is MHD beyond XDS-on-FHIR?

Healthcare Exchange Standards

Security and Privacy As with any Interoperability API dealing with Healthcare information, Security and Privacy are important. But IHE does encourage the use of ATNA, and IUA.This also described on the FHIR Site on the Security page. IHE doesn’t mandate a specific Security or Privacy model, as that would be Policy.

FHIR 40
article thumbnail

Review of Mobile Devices and Health by Ida Sim in the NEJM

mHealth Insight

who is a Primary Care Physician, Professor at UCSF & coFounder at Open mHealth (follow her on Twitter @IdaSim ). mHealth Insights. Widely used in the social and behavioral sciences, EMA is an emerging method for outcomes assessment in both clinical care and clinical research. Authored by Ida Sim, M.D.,